{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:55:32Z","timestamp":1776423332089,"version":"3.51.2"},"reference-count":43,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.3892\/ijo.2016.3358","type":"journal-article","created":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T07:26:16Z","timestamp":1453793176000},"page":"1599-1607","source":"Crossref","is-referenced-by-count":29,"title":["Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma"],"prefix":"10.3892","volume":"48","author":[{"given":"VISHWA JEET","family":"AMATYA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AMANY SAYED","family":"MAWAS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEI","family":"KUSHITANI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MOUCHIRA M.","family":"MOHI EL-DIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUKIO","family":"TAKESHIMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,1,26]]},"reference":[{"key":"key20180107185101_b1-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/oem.2003.010165","article-title":"Changing trends in US mesothelioma incidence","volume":"61","author":"Weill","year":"2004","journal-title":"Occup Environ Med"},{"key":"key20180107185101_b2-ijo-48-04-1599","first-page":"393","article-title":"Malignant mesothelioma mortality - United States, 1999\u20132005","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key20180107185101_b3-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.lungcan.2009.01.011","article-title":"Accuracy of pathological diagnosis of mesothelioma cases in Japan: Clinicopathological analysis of 382 cases","volume":"66","author":"Takeshima","year":"2009","journal-title":"Lung Cancer"},{"key":"key20180107185101_b4-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3892\/or.2012.2116","article-title":"CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma","volume":"29","author":"Amatya","year":"2013","journal-title":"Oncol Rep"},{"key":"key20180107185101_b5-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.currproblcancer.2004.04.001","article-title":"Malignant pleural mesothelioma","volume":"28","author":"Pass","year":"2004","journal-title":"Curr Probl Cancer"},{"key":"key20180107185101_b6-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180107185101_b7-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ijc.23874","article-title":"Survival of pleural malignant mesothelioma in Italy: A population-based study","volume":"124","author":"Montanaro","year":"2009","journal-title":"Int J Cancer"},{"key":"key20180107185101_b8-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: Small RNAs with a big role in gene regulation","volume":"5","author":"He","year":"2004","journal-title":"Nat Rev Genet"},{"key":"key20180107185101_b9-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/138920209787581299","article-title":"MicroRNA gene networks in Oncogenesis","volume":"10","author":"Drakaki","year":"2009","journal-title":"Curr Genomics"},{"key":"key20180107185101_b10-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s00018-014-1584-5","article-title":"Role of microRNAs in malignant mesothelioma","volume":"71","author":"Truini","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"key20180107185101_b11-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1165\/rcmb.2009-0060OC","article-title":"MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications","volume":"42","author":"Busacca","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"key20180107185101_b12-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1158\/1078-0432.CCR-10-3040","article-title":"Epigenetic silencing of microRNA-34b\/c plays an important role in the pathogenesis of malignant pleural mesothelioma","volume":"17","author":"Kubo","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180107185101_b13-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1158\/0008-5472.CAN-09-3993","article-title":"hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma","volume":"70","author":"Pass","year":"2010","journal-title":"Cancer Res"},{"key":"key20180107185101_b14-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/ijc.25285","article-title":"Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma","volume":"127","author":"Gee","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180107185101_b15-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"e18232","DOI":"10.1371\/journal.pone.0018232","article-title":"Association of miR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma","volume":"6","author":"Santarelli","year":"2011","journal-title":"PLoS One"},{"key":"key20180107185101_b16-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/JTO.0b013e3182572e83","article-title":"Increased circulating miR-625-3p: A potential biomarker for patients with malignant pleural mesothelioma","volume":"7","author":"Kirschner","year":"2012","journal-title":"J Thorac Oncol"},{"key":"key20180107185101_b17-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1349-7006.2006.00184.x","article-title":"Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients","volume":"97","author":"Usami","year":"2006","journal-title":"Cancer Sci"},{"key":"key20180107185101_b18-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2144\/000113083","article-title":"TScratch: A novel and simple software tool for automated analysis of monolayer wound healing assays","volume":"46","author":"Geb\u00e4ck","year":"2009","journal-title":"Biotechniques"},{"key":"key20180107185101_b19-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2144\/000112257","article-title":"CellProfiler: Free, versatile software for automated biological image analysis","volume":"42","author":"Lamprecht","year":"2007","journal-title":"Biotechniques"},{"key":"key20180107185101_b20-ijo-48-04-1599","first-page":"1369","article-title":"Overexpression of CD26\/DPPIV in mesothelioma tissue and mesothelioma cell lines","volume":"26","author":"Amatya","year":"2011","journal-title":"Oncol Rep"},{"key":"key20180107185101_b21-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/JTO.0b013e3181f1cf2b","article-title":"Malignant pleural mesothelioma: A population-based study of survival","volume":"5","author":"Milano","year":"2010","journal-title":"J Thorac Oncol"},{"key":"key20180107185101_b22-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"e80609","DOI":"10.1371\/journal.pone.0080609","article-title":"The miR-1-NOTCH3-Asef pathway is important for colorectal tumor cell migration","volume":"8","author":"Furukawa","year":"2013","journal-title":"PLoS One"},{"key":"key20180107185101_b23-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1007\/s13277-015-3358-6","article-title":"MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET","volume":"36","author":"Han","year":"2015","journal-title":"Tumour Biol"},{"key":"key20180107185101_b24-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"33394","DOI":"10.1074\/jbc.M804788200","article-title":"Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1","volume":"283","author":"Nasser","year":"2008","journal-title":"J Biol Chem"},{"key":"key20180107185101_b25-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"e98675","DOI":"10.1371\/journal.pone.0098675","article-title":"miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer","volume":"9","author":"Karatas","year":"2014","journal-title":"PLoS One"},{"key":"key20180107185101_b26-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ejca.2011.06.030","article-title":"The functional significance of miR-1 and miR-133a in renal cell carcinoma","volume":"48","author":"Kawakami","year":"2012","journal-title":"Eur J Cancer"},{"key":"key20180107185101_b27-ijo-48-04-1599","article-title":"The tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma","author":"Du","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"key20180107185101_b28-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1378\/chest.12-2770","article-title":"miR-1 induces growth arrest and apoptosis in malignant mesothelioma","volume":"144","author":"Xu","year":"2013","journal-title":"Chest"},{"key":"key20180107185101_b29-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"e44206","DOI":"10.1371\/journal.pone.0044206","article-title":"miR-214 targets \u03b2-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma","volume":"7","author":"Xia","year":"2012","journal-title":"PLoS One"},{"key":"key20180107185101_b30-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1111\/j.1742-4658.2012.08618.x","article-title":"Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist","volume":"279","author":"Li","year":"2012","journal-title":"FEBS J"},{"key":"key20180107185101_b31-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.febslet.2013.01.016","article-title":"miR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells","volume":"587","author":"Wang","year":"2013","journal-title":"FEBS Lett"},{"key":"key20180107185101_b32-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"e76994","DOI":"10.1371\/journal.pone.0076994","article-title":"MicroRNA profiling in prostate cancer - the diagnostic potential of urinary miR-205 and miR-214","volume":"8","author":"Srivastava","year":"2013","journal-title":"PLoS One"},{"key":"key20180107185101_b33-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"38705","DOI":"10.18632\/oncotarget.5478","article-title":"microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu)","volume":"6","author":"Long","year":"2015","journal-title":"Oncotarget"},{"key":"key20180107185101_b34-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"e0118086","DOI":"10.1371\/journal.pone.0118086","article-title":"MicroRNA-214 suppresses oncogenesis and exerts impact on prognosis by targeting PDRG1 in bladder cancer","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"key20180107185101_b35-ijo-48-04-1599","article-title":"Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1","author":"Phatak","journal-title":"Oncogene"},{"key":"key20180107185101_b36-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1365-2559.2010.03549.x","article-title":"Myogenic antigen expression is useful for differentiation between epithelioid mesothelioma and non-neoplastic mesothelial cells","volume":"56","author":"Tsukiji","year":"2010","journal-title":"Histopathology"},{"key":"key20180107185101_b37-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"D78","DOI":"10.1093\/nar\/gkt1266","article-title":"miRTarBase update 2014: An information resource for experimentally validated miRNA-target interactions","volume":"42D","author":"Hsu","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"key20180107185101_b38-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35090585","article-title":"Delineation of prognostic biomarkers in prostate cancer","volume":"412","author":"Dhanasekaran","year":"2001","journal-title":"Nature"},{"key":"key20180107185101_b39-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.4161\/cbt.7.9.6418","article-title":"Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma","volume":"7","author":"Reiser-Erkan","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"key20180107185101_b40-ijo-48-04-1599","first-page":"619","article-title":"Frequent down-regulation of pim-1 mRNA expression in non-small cell lung cancer is associated with lymph node metastases","volume":"20","author":"Warnecke-Eberz","year":"2008","journal-title":"Oncol Rep"},{"key":"key20180107185101_b41-ijo-48-04-1599","first-page":"4451","article-title":"Prognostic impact of protein overexpression of the proto-oncogene PIM-1 in gastric cancer","volume":"29","author":"Warnecke-Eberz","year":"2009","journal-title":"Anticancer Res"},{"key":"key20180107185101_b42-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1593\/neo.81038","article-title":"Pim-1 kinase expression predicts radiation response in squamocellular carcinoma of head and neck and is under the control of epidermal growth factor receptor","volume":"11","author":"Peltola","year":"2009","journal-title":"Neoplasia"},{"key":"key20180107185101_b43-ijo-48-04-1599","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13045-014-0095-z","article-title":"Pim kinases in hematological malignancies: Where are we now and where are we going?","volume":"7","author":"Mondello","year":"2014","journal-title":"J Hematol Oncol"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2016.3358\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T00:45:40Z","timestamp":1567557940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2016.3358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,26]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,1,26]]},"published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.3892\/ijo.2016.3358"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2016.3358","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,26]]}}}